{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-11-22T12:20:10.843925+00:00",
  "news": [
    {
      "title": "Amgen gets a full approval for Imdelltra | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxOdkdHX3pGYV9IcTN0YjZPMFVTQnpSbldyNjY4czdJcTBILTYyRW1OeklpVFFOb3VFU0JiR1ZZSUdSRnRIXzRBaGFGNTkyend4TURRVWdyejVhcDZORl9DREt5YW1TcXZwTW5zMmlTdDZ4M3p6SmtvUU1VMGJkSm1CSGN3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxOdkdHX3pGYV9IcTN0YjZPMFVTQnpSbldyNjY4czdJcTBILTYyRW1OeklpVFFOb3VFU0JiR1ZZSUdSRnRIXzRBaGFGNTkyend4TURRVWdyejVhcDZORl9DREt5YW1TcXZwTW5zMmlTdDZ4M3p6SmtvUU1VMGJkSm1CSGN3?oc=5\" target=\"_blank\">Amgen gets a full approval for Imdelltra | ApexOnco - Clinical Trials news and analysis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Oncology Pipeline</font>",
      "published": "2025-11-20T14:57:44+00:00",
      "source": "Oncology Pipeline"
    },
    {
      "title": "Amgen's Imdelltra receives full FDA approval in small cell lung cancer - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNVWJKV3hISVpZTnBRXy1pSEdabkN5TnpHa0pCRjdfdEFNeFZRRlRuM2ZkYUxRdG5EY3JtT3lDb21GcHpUMGlLU2JjMHJVdGFRalhTZ0JmRE5oTWVhU2lvTnQxcG9hTTNIUkhYUS1YOTZaeW4zN3FrcFFnejBYaXp3WW40RG5SMU1nblUzb2ZYbklkOC1BelU0QkNiWjhQNjZiOExtUGs2Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxNVWJKV3hISVpZTnBRXy1pSEdabkN5TnpHa0pCRjdfdEFNeFZRRlRuM2ZkYUxRdG5EY3JtT3lDb21GcHpUMGlLU2JjMHJVdGFRalhTZ0JmRE5oTWVhU2lvTnQxcG9hTTNIUkhYUS1YOTZaeW4zN3FrcFFnejBYaXp3WW40RG5SMU1nblUzb2ZYbklkOC1BelU0QkNiWjhQNjZiOExtUGs2Zw?oc=5\" target=\"_blank\">Amgen's Imdelltra receives full FDA approval in small cell lung cancer</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-11-19T22:29:33+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Low Relative Strength Ratings Didn't Deter Us From Medical Stocks - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNVjFEc2JVSjRTU0xNZ2FKdmhvSWN4RkJmc0ZuOWZMbGN4UzVuQmxPUVNadmZzcU1uY3hMdnlzY0RQeW9fN25IT3d5MXdOa0pGVldSTXl0ekQ3QllzUk9lamlLODZtT04zQnVoUlVqQzBsdDB2YW9nNVJ3Nk1NZkQ3OWg4Nms0SGZxMzlieVNWSlZrMkdmSUpvODFEZUhBZVdxRGVGTkE2NTNkNGVjelZ3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirwFBVV95cUxNVjFEc2JVSjRTU0xNZ2FKdmhvSWN4RkJmc0ZuOWZMbGN4UzVuQmxPUVNadmZzcU1uY3hMdnlzY0RQeW9fN25IT3d5MXdOa0pGVldSTXl0ekQ3QllzUk9lamlLODZtT04zQnVoUlVqQzBsdDB2YW9nNVJ3Nk1NZkQ3OWg4Nms0SGZxMzlieVNWSlZrMkdmSUpvODFEZUhBZVdxRGVGTkE2NTNkNGVjelZ3?oc=5\" target=\"_blank\">Low Relative Strength Ratings Didn't Deter Us From Medical Stocks</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-11-21T21:22:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "CEO of drugmaker Amgen talks new results from cholesterol drug trial - CNBC",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWnIyMTBzWlF3YTBDeVhfYlNYcnZBZ2RzQWpOamRxb3JSZU55MEdrUDRqdzZGT2o3VGNxa05Pc21hUThTZW9pS3lSWmFNWHZfaXJ0YmNodTVXNFhjM2hYZjBWeVpkSlVCakJHczRtOV94aWt2VlJQaU8zQWxCenZvZ1cyVmlJUDJSQUwzd0xZallhcldodk1jUjdnRk5RbkY3VUNPb29fWjLSAa4BQVVfeXFMTndXUncyNjdFRlpKT21TbEFRV2pMY1lDeTdEQ3NNcFlzLV9ScTJJZjFGdDRTWElDbHNGRXkwSkFMVFBxZVFQZzVDRWZmYVlJcEYxOVR6dGtKcEpOVDBlWXRSQVVxSGFnMUxxd2pMaTNmWkZGeTBCMVhGZ0lNbkFzNUlmcGZETUtFTXJkX01qblFRSTFHUG9kV3hVa29yWkNXTjFOZkxuNzY5SjZ6REl3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWnIyMTBzWlF3YTBDeVhfYlNYcnZBZ2RzQWpOamRxb3JSZU55MEdrUDRqdzZGT2o3VGNxa05Pc21hUThTZW9pS3lSWmFNWHZfaXJ0YmNodTVXNFhjM2hYZjBWeVpkSlVCakJHczRtOV94aWt2VlJQaU8zQWxCenZvZ1cyVmlJUDJSQUwzd0xZallhcldodk1jUjdnRk5RbkY3VUNPb29fWjLSAa4BQVVfeXFMTndXUncyNjdFRlpKT21TbEFRV2pMY1lDeTdEQ3NNcFlzLV9ScTJJZjFGdDRTWElDbHNGRXkwSkFMVFBxZVFQZzVDRWZmYVlJcEYxOVR6dGtKcEpOVDBlWXRSQVVxSGFnMUxxd2pMaTNmWkZGeTBCMVhGZ0lNbkFzNUlmcGZETUtFTXJkX01qblFRSTFHUG9kV3hVa29yWkNXTjFOZkxuNzY5SjZ6REl3?oc=5\" target=\"_blank\">CEO of drugmaker Amgen talks new results from cholesterol drug trial</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2025-11-10T08:00:00+00:00",
      "source": "CNBC"
    },
    {
      "title": "Amgen halts gastric cancer trial after antibody 'did not meet our standard' of efficacy, exec says - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQLWdIcTFDRGktWXR6N2ZCUUtKSzNTNTRtM3ZqQ2UwdmpuODc4VklpTTNkSFhRTE9jTE9sNFFmam9oZGJwelhfYVBseFJTVlJLOE1ocExaVlhRNHhhRmVrbkRWWXFrYjJpUVVoXzhhOHhvcVhaZTJmMU5lcW9jY3U3UkVjaFNUSk5MMTk5c0tzQXJ1bkRYbUxPWkdtN1JCX2hhQ2c4aGN4ZDJndWFubmJPd1JlNTdKUGNzdWhkVw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivAFBVV95cUxQLWdIcTFDRGktWXR6N2ZCUUtKSzNTNTRtM3ZqQ2UwdmpuODc4VklpTTNkSFhRTE9jTE9sNFFmam9oZGJwelhfYVBseFJTVlJLOE1ocExaVlhRNHhhRmVrbkRWWXFrYjJpUVVoXzhhOHhvcVhaZTJmMU5lcW9jY3U3UkVjaFNUSk5MMTk5c0tzQXJ1bkRYbUxPWkdtN1JCX2hhQ2c4aGN4ZDJndWFubmJPd1JlNTdKUGNzdWhkVw?oc=5\" target=\"_blank\">Amgen halts gastric cancer trial after antibody 'did not meet our standard' of efficacy, exec says</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2025-11-05T08:00:00+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "Amgen Raises Full-Year Outlook After Third-Quarter Profit, Sales Jump - The Wall Street Journal",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Amgen Raises Full-Year Outlook After Third-Quarter Profit, Sales Jump</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Wall Street Journal</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "The Wall Street Journal"
    },
    {
      "title": "Amgen’s cholesterol shot prevented first heart attacks and strokes, more detailed data affirm - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNWlZYNE1jbDZBQkJuelBaSnR0bFFqTXprSm9TSDJ5V2dVY0FYMVJwMGhndlFoaHFGOE5PNko3Qm5Ba2ZJdFdzckpFSVBfcWxNUEtWRmRidzlTalRZLUxzSjFSY2dNV25GMDRjSTF6VjVyUk1WZ3cyMmZCalloN3BWcDBVTnRKN2tMblE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxNWlZYNE1jbDZBQkJuelBaSnR0bFFqTXprSm9TSDJ5V2dVY0FYMVJwMGhndlFoaHFGOE5PNko3Qm5Ba2ZJdFdzckpFSVBfcWxNUEtWRmRidzlTalRZLUxzSjFSY2dNV25GMDRjSTF6VjVyUk1WZ3cyMmZCalloN3BWcDBVTnRKN2tMblE?oc=5\" target=\"_blank\">Amgen’s cholesterol shot prevented first heart attacks and strokes, more detailed data affirm</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-11-08T08:00:00+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices - The New York Times",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5\" target=\"_blank\">Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The New York Times</font>",
      "published": "2025-11-03T08:00:00+00:00",
      "source": "The New York Times"
    }
  ],
  "product_launches": [
    {
      "title": "Biosimilars referencing Amgen’s Neulasta and Neupogen launch in Canada and US - Generics and Biosimilars Initiative",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPbnVybHpDRTRJOEZIM3NmLXBqaHI1LXVXbUMwNS1LTmY4WlFRYUxvUFFrdXdxdmhoeGg1Zm43b3lGMEpSYUFzVVA3emZDNXloUjhNcS1NWHJkTlB2V2FqeGtEQ182RjFTM2M3X0xkazc4c2FyNGRzWGVPSGhtYXlqUjM2MmR4bWg1aGkxNjhnTl9PbS1KbE1wY3dQYTNFTlZ5bjNjOTBNRkZvNDlkSGh0SmNBSkZiTHJP?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPbnVybHpDRTRJOEZIM3NmLXBqaHI1LXVXbUMwNS1LTmY4WlFRYUxvUFFrdXdxdmhoeGg1Zm43b3lGMEpSYUFzVVA3emZDNXloUjhNcS1NWHJkTlB2V2FqeGtEQ182RjFTM2M3X0xkazc4c2FyNGRzWGVPSGhtYXlqUjM2MmR4bWg1aGkxNjhnTl9PbS1KbE1wY3dQYTNFTlZ5bjNjOTBNRkZvNDlkSGh0SmNBSkZiTHJP?oc=5\" target=\"_blank\">Biosimilars referencing Amgen’s Neulasta and Neupogen launch in Canada and US</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Generics and Biosimilars Initiative</font>",
      "published": "2025-11-21T06:21:31+00:00",
      "source": "Generics and Biosimilars Initiative"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance - TradingView",
      "link": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNN09XMkFVU05lZ0ZfVnZnbzkzU3NuNklBWEhsUWtkbVpTOHhHVHEzbk5PSEpGVEY1dUFjLTFLY3U5ZUg1RlhWZm1MR2hqNEd2ZWotTmx5T20wZjhseDBNcTdkdXlELXJvZjRZUVpDR1VXYTdtWmxHX3ZRLXFnRFBIb3VfWk4wSk5fV0ZoNGVSNFNhbkZqUHBhZXc2a0lQZ2Exa2w4eVJZakRFSk5uczBZcmJvSnlXVWRVNHQyV1M0MDZXd2l6X3dFbk5ua0p2UE1VUV9HV0xFS1ppLXZEdFJmRllmR1A1QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNN09XMkFVU05lZ0ZfVnZnbzkzU3NuNklBWEhsUWtkbVpTOHhHVHEzbk5PSEpGVEY1dUFjLTFLY3U5ZUg1RlhWZm1MR2hqNEd2ZWotTmx5T20wZjhseDBNcTdkdXlELXJvZjRZUVpDR1VXYTdtWmxHX3ZRLXFnRFBIb3VfWk4wSk5fV0ZoNGVSNFNhbkZqUHBhZXc2a0lQZ2Exa2w4eVJZakRFSk5uczBZcmJvSnlXVWRVNHQyV1M0MDZXd2l6X3dFbk5ua0p2UE1VUV9HV0xFS1ppLXZEdFJmRllmR1A1QQ?oc=5\" target=\"_blank\">AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>",
      "published": "2025-11-05T08:00:00+00:00",
      "source": "TradingView"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-11-21",
      "close": 337.5400085449219
    },
    "history": [
      {
        "date": "2025-11-13",
        "close": 333.6204833984375
      },
      {
        "date": "2025-11-14",
        "close": 334.3552551269531
      },
      {
        "date": "2025-11-17",
        "close": 339.2900390625
      },
      {
        "date": "2025-11-18",
        "close": 341.55389404296875
      },
      {
        "date": "2025-11-19",
        "close": 339.97515869140625
      },
      {
        "date": "2025-11-20",
        "close": 333.69000244140625
      },
      {
        "date": "2025-11-21",
        "close": 337.5400085449219
      }
    ],
    "name": "Amgen Inc."
  }
}